With an almost two-decade presence in Egypt, Macro Group Pharmaceuticals is a pioneer and market-leader in the country’s cosmeceutical space. The company has steadily grown in size to lead the highly fragmented market in terms of sales by catering to multiple demographic segments with a well-developed portfolio of products diversified across 7 high-growth therapeutic areas within cosmeceuticals and 1 newly added therapeutic area under nutraceuticals.
Read More
Highlights
-
8
Therapeutic Areas
FY22 -
149 SKUs
Portfolio Size
FY22 -
31%/1st
Market Share/Rank
FY22
Consolidated Financials 2018-20
PDF - DownloadOur Strategy
With a clear and well-articulated growth strategy underpinned by a number of expansion pillars, Macro Group has set in motion a number of growth avenues with the ultimate objective to develop its brand equity, increase its top line, and enhance its margins:
- Enhance current portfolio and increase penetration of large and fast growing therapeutic areas
- Offer products at attractive price points with higher margins, capturing larger market shares
- Diversify portfolio by expanding into new segments
- Direct to consumer (“DTC”) market development strategy and e-commerce initiatives
- Inorganic expansion
